Deion Sanders promoted Chris Marve to defensive coordinator, giving Colorado a rare case of having a Black head coach with two Black coordinators ...

The culture will pull up to Wrigley Field as Prairie View A&M and Alabama A&M will meet in Chicago's first-ever HBCU Baseball Classic.

A breakthrough personalized mRNA cancer vaccine that trains the immune system to target patients' unique tumor mutations is showing promising results. Five-year trial data show the risk of recurrence ...

Breakthrough therapy designation targets the post-CDK4/6 setting in PIK3CA-mutant HR+/HER2− advanced disease, where progression is common and therapeutic options remain constrained. Phase 1/2 ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

Please provide your email address to receive an email when new articles are posted on . FDA has granted breakthrough designation for litifilimab in patients with cutaneous lupus erythematosus. The ...

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from ...

While clinical data have improved, Altimmune remains a "cautious Hold" as the stock balances significant regulatory wins against intensifying competitive pressure. 48-week data showed statistically ...

Please provide your email address to receive an email when new articles are posted on . Ianalumab has received the FDA’s breakthrough therapy designation for Sjögren’s disease. Novartis plans to ...

Regulatory submission for ianalumab in Sjögren disease is expected in early 2026, according to Novartis. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...

Eli Lilly and Co. has received the U.S. Food and Drug Administration’s breakthrough therapy designation for a drug in development to treat certain ovarian cancer patients. The Indianapolis-based ...